{"contentid": 488190, "importid": NaN, "name": "UK biotech set for another year of record-breaking investment", "introduction": "UK biotech companies are on track for a record-breaking year of fundraising according to the latest data released by the UK BioIndustry Association (BIA) and Clarivate.", "content": "<p>UK biotech companies are on track for a record-breaking year of fundraising according to the latest data released by the UK BioIndustry Association (BIA) and Clarivate.</p>\n<p>More than &pound;830 million ($1.14 billion) in fresh capital was raised in the three months to the end of February, almost topping the &pound;894 million raised in the first six months of 2020, which itself was a record-breaking year.</p>\n<p>Global investors continue to recognise the high potential of UK science, with both public and private companies securing large investments to finance their R&amp;D programs and accelerate the delivery of innovative medicines to patients.</p>\n<p>Highlights from the data include:</p>\n<ul>\n<li>&pound;336 million was raised in venture capital between December 2020 and February 2021, up from &pound;123 million in the same period a year ago;</li>\n<li>&pound;215 million was raised through initial public offerings (IPOs), up from &pound;0 a year ago; and</li>\n<li>&pound;279 million was raised through follow-on financings, up from &pound;186 million a year ago</li>\n</ul>\n<p>Responding to the news, BIA chief executive Steve Bates noted: &ldquo;This strong start to 2021, with investments outpacing the record setting year of 2020, shows the incredible appetite amongst international and some domestic investors for the UK&rsquo;s world leading biotech and life sciences companies. &nbsp;</p>\n<p>&ldquo;This has been reinforced by the recent announcement that &pound;1 billion will be invested in the sector through a <a href=\"https://www.thepharmaletter.com/article/uae-investment-a-boost-for-uk-life-sciences\">UAE-UK Sovereign Investment Partnership.</a> This quarter has also seen significant private sector investments into UK medicine manufacturing capability and clinical development pipelines, which has fuelled increased confidence in the sectors outlook for 2021.&rdquo;</p>\n<p>Globally, &pound;7.2 billion venture capital has been invested into private biotech companies, &pound;888m of it in Europe. The UK accounted for almost 38% of the European total.</p>\n<p><strong>UK biotech is providing strong returns for investors</strong></p>\n<p>Alongside the high levels of investment, the UK&rsquo;s maturing biotech sector is providing strong returns for its financial backers.</p>\n<p>An analysis by Radnor Capital Partners on behalf of the BIA found that biotech companies quoted on the London Stock Exchange have out-performed the FTSE-All Share by 256% in the past year (unweighted), with listed collective investment vehicles, which are favored by retail investors because they diversify risk, rising 60.4% compared to the FTSE All-Share.</p>\n<p>As markets have started to rebound as the pandemic in the UK eases, the sector has continued to outperform, with the FTSE All-Share rising by only 4% against 24% for the quoted biotech sector (unweighted, or 14% on a market cap weighted basis).</p>\n<p>With the new UK financial tax year soon to begin, sector experts are confident that UK biotech and life sciences companies, as well as funds dedicated to investing into the sector, will be a more popular location for retail investors.</p>", "date": "2021-03-30 10:27:00", "meta_title": "UK biotech set for another year of record-breaking investment", "meta_keywords": "BioIndustry Association, BIA, Clarivate, Fundraising, IPOs, Venture capital, Investors, Returns", "meta_description": "UK biotech set for another year of record-breaking investment", "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 3, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-03-30 09:04:17", "updated": "2021-03-30 10:27:33", "access": NaN, "url": "https://www.thepharmaletter.com/article/uk-biotech-set-for-another-year-of-record-breaking-investment", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "bia_logo_large.jpg", "image2id": "bia_logo_small.jpg", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": NaN, "sector_tag": "Biotechnology", "therapy area_tag": NaN, "topic_tag": "Business Financing", "geography_tag": "UK", "company_tag": "BIA, Clarivate Analytics", "drug_tag": NaN, "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-03-30 10:27:00"}